SIM
CLVS

Spark Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Spark Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,700
Closed -$92K – 88
2020
Q2 		$92K Sell
13,700
-76,500
-85% -$579K 0.34% 50
2020
Q1 		$573K Sell
90,200
-46,300
-34% -$371K 0.3% 112
2019
Q4 		$1.42M Sell
136,500
-573,100
-81% -$4.17M 0.17% 177
2019
Q3 		$2.79M Sell
709,600
-99,669
-12% -$806K 0.36% 92
2019
Q2 		$12M Buy
809,269
+136,169
+20% +$2.46M 0.83% 20
2019
Q1 		$16.7M Buy
673,100
+227,800
+51% +$5.71M 0.77% 28
2018
Q4 		$8M Buy
445,300
+413,000
+1,279% +$8.44M 0.55% 40
2018
Q3 		$948K Buy
+32,300
New +$1.25M 0.05% 392
2017
Q2 		– Sell
-71,800
Closed -$4.57M – 891
2017
Q1 		$4.57M Buy
+71,800
New +$4.36M 0.29% 91
2016
Q2 		– Sell
-112,500
Closed -$2.16M – 871
2016
Q1 		$2.16M Buy
112,500
+2,500
+2% +$52.9K 0.22% 144
2015
Q4 		$3.85M Buy
+110,000
New +$7.09M 0.49% 39
2015
Q3 		– Sell
-7,000
Closed -$615K – 776
2015
Q2 		$615K Buy
+7,000
New +$599K 0.09% 313

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Spark Investment Management's CLVS Position: Q3 2020 in Review

Spark Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2020, closing a stake of 13,700 shares — an estimated $92K sold.

Spark Investment Management first reported a position in CLVS in Q2 2015 and held it in 12 quarters. The position peaked at $16.7M in Q1 2019. 169 funds tracked by Wall St. Rank hold CLVS as of Q3 2020.

  • Spark Investment Management reported no remaining Clovis Oncology, Inc. position as of Q3 2020 after selling out during the quarter.
  • Spark Investment Management sold 13,700 Clovis Oncology, Inc. shares in Q3 2020, an estimated $92K.
  • Spark Investment Management first reported a position in Clovis Oncology, Inc. in Q2 2015 and held it in 12 quarters.
  • Spark Investment Management's Clovis Oncology, Inc. position peaked at $16.7M in Q1 2019.
  • 169 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2020.

Based on Spark Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.